Antisense proliferating cell nuclear antigen oligonucleotides inhibit intimal hyperplasia in a rat carotid artery injury model

J Clin Invest. 1994 Jun;93(6):2351-6. doi: 10.1172/JCI117240.

Abstract

We have used antisense phosphorothioate oligonucleotides to define the role played by proliferating cell nuclear antigen (PCNA) in neointimal accumulation of smooth muscle cells in a rat carotid artery injury model. The short-term extraluminal delivery of 250 nmol of antisense oligonucleotides, but not control oligonucleotides, immediately after arterial injury produces a 77% suppression of PCNA mRNA after 24 h and a 52% decrease in the frequency of medial smooth muscle cells expressing PCNA after 72 h. This reduction in PCNA expression is accompanied by a 59% decrease in the frequency of proliferating medial smooth muscle cells at 3 d as measured by BudR staining and an 80% decrease in neointimal accumulation assessed morphometrically at 2 wk. Thus, the expression of PCNA is required for medial smooth muscle cell growth in vivo and for neointimal formation after arterial injury.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Base Sequence
  • Carotid Arteries / pathology
  • Cell Division
  • Cell Line
  • Hyperplasia
  • Molecular Sequence Data
  • Muscle, Smooth, Vascular / pathology*
  • Nuclear Proteins / analysis
  • Nuclear Proteins / physiology*
  • Oligonucleotides, Antisense / pharmacology*
  • Proliferating Cell Nuclear Antigen
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Nuclear Proteins
  • Oligonucleotides, Antisense
  • Proliferating Cell Nuclear Antigen